Stereotaxis (STXS) EBITDA (2010 - 2026)
Stereotaxis (STXS) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM Stereotaxis (STXS) EBITDA is -$22M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Stereotaxis (STXS) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -14.93% |
| 3 Years TTM | +2.80% |
| 5 Years TTM | +28.86% |
| 10 Years TTM | +15.42% |
| All Time TTM | -0.09% |
Annual EBITDA change of Stereotaxis (STXS)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$5.82M | -72.92% |
| 2025 | -$21M | -11.01% |
| 2024 | -$24M | +13.70% |
| 2023 | -$21M | +15.75% |
| 2022 | -$18M | +43.58% |
| 2021 | -$13M | +93.93% |
| 2020 | -$6.59M | +40.21% |
| 2019 | -$4.70M | +142.27% |
| 2018 | -$1.94M | -63.87% |
| 2017 | -$5.37M | -11.39% |
| 2016 | -$6.06M | +19.06% |
| 2015 | -$5.09M | +2.41% |
| 2014 | -$4.97M | -37.25% |
| 2013 | -$7.92M | -15.11% |
| 2012 | -$9.33M | -69.39% |
| 2011 | -$30M | +76.59% |
| 2010 | -$17M | -20.79% |
| 2009 | -$22M | N/A |
Comparison Stereotaxis (STXS) five years EBITDA CAGR with competitors
Stereotaxis (STXS) five years EBITDA CAGR is 28.84%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| POCI | Precision Optics Corp Inc | 111.37% | +286.18% |
| NYXH | Nyxoah SA | 45.05% | +56.21% |
| GCTK | GlucoTrack Inc | 38.94% | +35.01% |
| ZTEK | Zentek Ltd | 26.96% | -6.52% |
| RGNT | Regentis Biomaterials Ltd | 26.85% | -6.91% |
| MMSI | Merit Medical Systems Inc | 24.73% | -14.25% |
| BLFS | Biolife Solutions Inc | 22.17% | -23.14% |
| ISRG | Intuitive Surgical Inc | 21.90% | -24.05% |
| RGEN | Repligen Corp | 15.86% | -45.02% |
| RMD | Resmed Inc | 15.14% | -47.48% |
| ALC | Alcon Inc | 14.84% | -48.53% |
| LMAT | Lemaitre Vascular Inc | 14.82% | -48.60% |
| PDEX | Pro-Dex Inc (co) | 13.53% | -53.10% |
| ANGO | Angiodynamic Inc | 12.62% | -56.23% |
| MBOT | Microbot Medical Inc | 11.58% | -59.84% |
| COO | Cooper Companies Inc | 7.73% | -73.19% |
| NXGL | Nexgel Inc | 7.05% | -75.56% |
| ATR | Aptargroup Inc | 6.79% | -76.44% |
| PLSE | Pulse Biosciences Inc | 6.69% | -76.79% |
| WST | West Pharmaceutical Services Inc | 6.51% | -77.43% |
| ICUI | ICU Medical Inc | 5.71% | -80.21% |
| ALGN | Align Technology Inc | 4.82% | -83.27% |
| EKSO | Ekso Bionics Holdings Inc | 4.60% | -84.06% |
| BDX | Becton Dickinson & Company | 4.54% | -84.26% |
| NVST | Envista Holdings Corp | 4.52% | -84.32% |